Georgetown University Clinical Research Unit (CRU) — Washington D.C., District of Columbia

Georgetown University Clinical Research Unit (CRU) is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown University Clinical Research Unit (CRU) has participated in 1 clinical trials.

Therapeutic areas: Alzheimer's Disease.

Sponsors: Biogen.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Clinical Research Unit (CRU)?

Georgetown University Clinical Research Unit (CRU) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Clinical Research Unit (CRU) conducted?

Georgetown University Clinical Research Unit (CRU) has 1 clinical trials on record. Their work covers Alzheimer's Disease.

Is Georgetown University Clinical Research Unit (CRU) accredited by Crixeo Health?

Georgetown University Clinical Research Unit (CRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Clinical Research Unit (CRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.